{"content":[{"text":"About this tool: \n The use of Xanax (alprazolam) has grown significantly over the past few years as the benzodiazepine, \n widely used in the US to treat anxiety, becomes more widely available in the UK.","bbox":{"left":0.036889,"top":0.047204,"width":0.918548,"height":0.06312700000000002}},{"text":"As with other benzodiazepines, Xanax can cause physical and psychological dependency. \n The exercises in the pack are intended to be used (for example) over successive weeks of face-to face \n sessions. They could also be completed by person using Xanax on their own, but it is likely that the \n person will benefit from discussion and interpretation of results. \n The programme follows the stages of The Cycle of Change, and is intended to support the process to \n the point of action. \n Who should use the tool? \n Some young people using Xanax will be recreational or experimental users and will have little or no \n dependency. In such situations, where no complicating factors are identified, the cessation programme \n can be followed in generic, non-drug specific settings. As such workers in numerous settings including \n Youth Workers, School Nurses and housing settings are well placed to work with cessation. It is of \n course also suitable for those primarily working in drug settings.","bbox":{"left":0.036889,"top":0.125947,"width":0.9237730000000001,"height":0.26777699999999993}},{"text":"Where there is a significant level of dependency, poly-drug use or a history of drug dependency, or \n mental illness, referral to or joint working with a drugs agency and/or mental health services is strongly \n advised.","bbox":{"left":0.036889,"top":0.409322,"width":0.919448,"height":0.05774499999999999}},{"text":"Acute withdrawal from benzodiazepines can be dangerous and has the potential to be life- \n threatening. Where there physical dependency is suspected a full medical assessment is \n required before stopping use.","bbox":{"left":0.036889,"top":0.48276,"width":0.8721040000000001,"height":0.057780999999999916}},{"text":"Which drugs are covered by this tool? \n The tool refers primarily to Xanax but is also relevant to other benzodiazepines, Z-drugs (zopiclone, \n zimovane and related drugs) and Pregabalin or Gabapentin (although withdrawal symptoms will tend \n to be less significant with the last two drugs.)","bbox":{"left":0.036889,"top":0.555635,"width":0.905617,"height":0.08145000000000002}},{"text":"These drugs are prescribed for serious anxiety, and insomnia, muscle spasm and several other \n medical conditions. They are also used outside of medical settings.","bbox":{"left":0.036889,"top":0.652711,"width":0.8559680000000001,"height":0.03940099999999991}},{"text":"The context of the tool is young people’s use of Xanax in recreational or self-medicating settings rather \n than longer term use of benzos as an aspect of dependent, prescribed or polydrug use.","bbox":{"left":0.036889,"top":0.707711,"width":0.923073,"height":0.03940100000000002}},{"text":"The tool isn’t designed to explore GHB/GBL as the patterns of use and context are significantly \n different.","bbox":{"left":0.036889,"top":0.765314,"width":0.852166,"height":0.036797999999999886}},{"text":"Further information about Benzodiazepines: \n The KFx briefing on Benzodiazepines can be downloaded here: \n http://www.kfx.org.uk/drug_facts/drug_facts_images_and_pdfs/benzos2017.pdf","bbox":{"left":0.036889,"top":0.817829,"width":0.712489,"height":0.05765599999999993}},{"text":"This resource is @nticopyright. You are welcome to use and redistribute provided that credit is given and the \n document is not altered without consent. Source: kevin@kfx.org.uk www.kfx.org.uk This version: September \n 2019","bbox":{"left":0.080711,"top":0.936729,"width":0.809994,"height":0.047209000000000056}}],"images_bbox":[],"images_bbox_not_text_overlap":[]}